Linezolid is an oxazolidinone antibiotic and is effective against Gram-positive bacteria including certain strains of methicillin-resistant Staphylococcus aureus (MRSA). Linezolid was discovered in the mid-1990s and was approved for commercial use in 2000. The crystal structure was elucidated in 2008 by Yale researchers. The compound is synthetic, and many apporaches for Linezolid synthesis have been reported. It is active against Gram-positive bacteria including certain methicillin-resistant Staphylococcus aureus (MRSA).
